🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Songqing Fan

ORCID: 0000-0002-1486-9909
MedicineComputer ScienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Overcoming acquired resistance of epidermal growth factor receptor‐mutant non–small cell lung cancer cells to osimertinib by combining osimertinib with the histone deacetylase inhibitor panobinostat (LBH589)”.

Overcoming acquired resistance of epidermal growth factor receptor‐mutant non–small cell lung cancer cells to osimertinib by combining osimertinib with the histone deacetylase inhibitor panobinostat (LBH589)

Cancer(2020)10.1002/cncr.32744
N/A
0DataRank · unranked
48 citations

Guoqing Qian, Dan Zong, Songqing Fan, Taofeek K. Owonikoko, Suresh S. Ramalingam +2 more

Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation EGFR Tyrosine Kinase Inhibitor, Osimertinib

Cancer Research(2021)10.1158/0008-5472.can-21-0556
N/A
0DataRank · unranked
67 citations

Zhen Chen, Hongjing Zang, Songqing Fan, Jiajia Gu, Guojing Zhang +7 more

Membrane-Associated RING-CH 8 Functions as a Novel PD-L1 E3 Ligase to Mediate PD-L1 Degradation Induced by EGFR Inhibitors

Molecular Cancer Research(2021)10.1158/1541-7786.mcr-21-0147
N/A
0DataRank · unranked
43 citations

Jianping Guo, Karin A. Vallega, C. Hu, Zhen Chen, Yunfu Deng +7 more

Data from Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation EGFR Tyrosine Kinase Inhibitor, Osimertinib

(2023)10.1158/0008-5472.c.6513256.v1
N/A
0DataRank · unranked
0 citations

Zhen Chen, Hongjing Zang, Songqing Fan, Jiajia Gu, Guojing Zhang +7 more

DNA topoisomerase II inhibition potentiates osimertinib’s therapeutic efficacy in EGFR-mutant non–small cell lung cancer models

Journal of Clinical Investigation(2024)10.1172/jci172716
N/A
0DataRank · unranked
30 citations

Karin A. Vallega, Dongsheng Wang, Zihan Quan, Songqing Fan, Qiming Wang +4 more

Inhibition of hTERT/telomerase/telomere mediates therapeutic efficacy of osimertinib in EGFR mutant lung cancer

The Journal of Experimental Medicine(2024)10.1084/jem.20240435
N/A
0DataRank · unranked
15 citations

Karin A. Vallega, Dongsheng Wang, Zihan Quan, Songqing Fan, Qiming Wang +4 more

Targeting Transient Receptor Potential Melastatin‐2 (TRPM2) Enhances Therapeutic Efficacy of Third Generation EGFR Inhibitors against EGFR Mutant Lung Cancer

Advanced Science(2024)10.1002/advs.202310126
N/A
0DataRank · unranked
10 citations

Karin A. Vallega, Vijay K. Boda, Zihan Quan, Dongsheng Wang, Songqing Fan +5 more